Billiontoone Inc - Class A

Research Billiontoone Inc - Class A (BLLN) on Bullrun: valuation model: 67.8% overvalued, market cap USD 5.54B, P/E 260.2. Explore financials, valuation history, model signals, and stock context.

Key Metrics

TickerBLLN
ExchangeNASDAQ
CountryUnited States
SectorHealthcare
IndustryDiagnostics & Research
CurrencyUSD
Valuation signal67.8% overvalued
Market capUSD 5.54B
P/E260.2
Financial periodFY2025
RevenueUSD 305.11M
Revenue growth100.0%
Net incomeUSD 7.45M
Free cash flowUSD 15.71M
Gross margin68.3%

Valuation Snapshot

Bullrun's latest valuation model marks Billiontoone Inc - Class A as 67.8% overvalued; latest market cap is USD 5.54B; P/E is 260.2.

About Billiontoone Inc - Class A

BillionToOne, Inc., a precision diagnostics company, quantifies biology to create molecular diagnostics. The company provides molecular counting platform, which is designed to detect and measure DNA molecules at the single-count level to help enhance disease detection. It also offers UNITY Complete, a non-invasive prenatal screen that assesses fetal risk for aneuploidies, recessive conditions, and fetal antigens from a maternal blood draw;

Frequently asked questions

Is Billiontoone Inc - Class A overvalued or undervalued?

Bullrun's valuation model currently marks Billiontoone Inc - Class A as 67.8% overvalued.

What is Billiontoone Inc - Class A's market cap?

Billiontoone Inc - Class A's market capitalization is USD 5.54B.

What is Billiontoone Inc - Class A's P/E ratio?

Billiontoone Inc - Class A's price-to-earnings (P/E) ratio is 260.2.